NZ academics say DTC advertising of Rx drugs should be banned News item 10 February 2013 Pages: 2 - 2
UK NICE issues guidance on antivirals, insulin and vaginal tape News item 10 February 2013 Pages: 2 - 2
Health interventions “very cost effective” in less-developed countries Clinical study 10 February 2013 Pages: 5 - 5
Pneumonia quality of care enhanced with feedback intervention Clinical study 10 February 2013 Pages: 5 - 5
Endoscopic screening worth it for pancreatic cancer in the US Clinical study 10 February 2013 Pages: 6 - 6
Hormonal contraception use: no effect on HIV-1 acquisition Clinical study 10 February 2013 Pages: 6 - 6
Chemotherapy use diverges from US breast cancer guidelines Clinical study 10 February 2013 Pages: 7 - 7
Levosalbutamol yields “economic advantages” in asthma, COPD Clinical study 10 February 2013 Pages: 8 - 8
Camera-based screening for diabetic retinopathy well worth it in Canada Clinical study 10 February 2013 Pages: 9 - 9
Herbal medicine use among US paediatrics with ADHD, depressive disorders Clinical study 10 February 2013 Pages: 10 - 10
Major depression increases costs among US elderly with diabetes Clinical study 10 February 2013 Pages: 10 - 10
Omeprazole cost-effective adjuvant therapy for peptic ulcer in Hong Kong Clinical study 10 February 2013 Pages: 10 - 10
Reference pricing blood glucose test strips to save millions in NZ Media release 10 February 2013 Pages: 11 - 11
US FDA receives 21% boost in programme level budget for FY2003 Media release 10 February 2013 Pages: 11 - 11
Nearly one-quarter market share for hep C prescriptions held by Roche's PEG IFN-α-2a News item 10 February 2013 Pages: 12 - 12
New insulin guidelines could cost UK NHS $US11 million annually News item 10 February 2013 Pages: 12 - 12